Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials

Medicin og biovidenskab

• Tumor Necrosis Factor Inhibitors 100%
• Antirheumatic Agents 98%
• Rheumatoid Arthritis 68%
• Meta-Analysis 61%
• Biological Factors 29%
• Health Care Costs 24%
• Steroids 20%
• Rheumatology 14%
• Drug Combinations 14%
• Therapeutics 13%
• Methotrexate 13%
• Randomized Controlled Trials 9%
• Guidelines 8%
• Costs and Cost Analysis 8%
• Drug Therapy 8%